(VIANEWS) – The NASDAQ ended the session with Vertex Pharmaceuticals (VRTX) jumping 4.7% to $287.78 on Friday while NASDAQ dropped 0.5% to $12,657.55.


Today’s last reported volume for Vertex Pharmaceuticals is 2015280, 21.28% above its average volume of 1661630.

Vertex Pharmaceuticals’s last close was $274.85, 7.41% under its 52-week high of $296.84.

The company’s growth estimates for the ongoing quarter and the next is 13.2% and 0.8%, respectively.

Vertex Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 27.3%, now sitting on 7.57B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Vertex Pharmaceuticals’s stock is considered to be oversold (<=20).

Vertex Pharmaceuticals’s Stock Yearly Top and Bottom Value

Vertex Pharmaceuticals’s stock is valued at $287.78 at 19:34 EST, under its 52-week high of $296.84 and way higher than its 52-week low of $176.36.

Vertex Pharmaceuticals’s Moving Average

Vertex Pharmaceuticals’s value is above its 50-day moving average of $275.65 and way above its 200-day moving average of $240.36.

More news about Vertex Pharmaceuticals (VRTX).


Please enter your comment!
Please enter your name here